Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-23-022049

Sr. VP, R&D & CSO sold 2,412 shares at $9.63 ($23,228)

From the SEC's structured data for this filing

Trades in this filing

Or Yat Sun · Sr. VP, R&D & CSO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-12-05 Sale : show line 1 in the form −2,412 $9.63 $23,228 370,695 D
Open-market sales · 2,412 sh · avg $9.63 · $23,228
Loading xslF345X05/form4.xml…